On Monday, Mustang Bio Inc (NASDAQ: MBIO) opened higher 35.00% from the last session, before settling in for the closing price of $0.22. Price fluctuations for MBIO have ranged from $0.13 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 86.50% at the time writing. With a float of $33.65 million, this company’s outstanding shares have now reached $37.23 million.
Let’s look at the performance matrix of the company that is accounted for 80 employees. In terms of profitability, gross margin is 5.97%, operating margin of -1142.75%, and the pretax margin is -1112.56%.
Mustang Bio Inc (MBIO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mustang Bio Inc is 9.62%, while institutional ownership is 2.39%.
Mustang Bio Inc (MBIO) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2023, the company posted -2.06 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -3.01) by 0.95. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 86.50% per share during the next fiscal year.
Mustang Bio Inc (NASDAQ: MBIO) Trading Performance Indicators
Check out the current performance indicators for Mustang Bio Inc (MBIO). In the past quarter, the stock posted a quick ratio of 0.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.98, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Mustang Bio Inc (MBIO)
Mustang Bio Inc (NASDAQ: MBIO) saw its 5-day average volume 1.18 million, a negative change from its year-to-date volume of 9.51 million. As of the previous 9 days, the stock’s Stochastic %D was 52.65%. Additionally, its Average True Range was 0.02.
During the past 100 days, Mustang Bio Inc’s (MBIO) raw stochastic average was set at 14.11%, which indicates a significant decrease from 98.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 129.92% in the past 14 days, which was lower than the 307.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2724, while its 200-day Moving Average is $0.6101. Nevertheless, the first resistance level for the watch stands at $0.3211 in the near term. At $0.3486, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4022. If the price goes on to break the first support level at $0.2400, it is likely to go to the next support level at $0.1864. Assuming the price breaks the second support level, the third support level stands at $0.1589.
Mustang Bio Inc (NASDAQ: MBIO) Key Stats
There are currently 12,515K shares outstanding in the company with a market cap of 10.93 million. Presently, the company’s annual sales total 0 K according to its annual income of -51,600 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -8,200 K.
